Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review

Stefano Palomba, Caterina Materazzo, Angela Falbo, Francesco Orio, Giovanni Battista La Sala, Charles Sultan

Research output: Contribution to journalArticlepeer-review

Abstract

The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment.

Original languageEnglish
Pages (from-to)335-340
Number of pages6
JournalGynecological Endocrinology
Volume30
Issue number5
DOIs
Publication statusPublished - 2014

Keywords

  • Adolescents
  • Metformin
  • Oligo-amenorrhea
  • Oral contraceptives
  • PCOS

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Obstetrics and Gynaecology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review'. Together they form a unique fingerprint.

Cite this